In the first quarter of 2014, Lonza’s business performance was fully in line with expectations, according to company executives. In both the specialty ingredients and pharma & biotech segments, Lonza realized our growth targets and achieved a better performance than in the same period of the previous year.
“I’m pleased with the performance of our businesses in the first quarter," said Richard Ridinger, CEO. "The good results show that we have embarked on the right path with our transformational initiatives, which make us more competitive and more market oriented. We also continue to work diligently on operational improvements and quality initiatives across the company in all regions.”
The specialty ingredients segment had a good start for 2014 with positive overall market demand in most areas. In consumer care the hygiene business had a particularly encouraging start.